fbpx

Our History

1941: Alfredo Kuster, a Swiss businessman, created a company to represent Swiss pharmaceutical companies in Venezuela. FARMA • Strategic alliances with Sandoz (Switzerland) and the Swiss Serum and Vaccine Institute Berne (Switzerland). The beginning of GRUPO 1952: Inauguration of the Caracas headquarters.

1955: Grupo Farma signed license agreements with J.R. Geigy and Hoffmann-La Roche and undertook the distribution of the Nestle milk “Guigoz”.
1960: We began operations in Colombia, making Grupo Farma the first pharmaceutical transnational company of Andean origin. 1964: The Berne Institute of Spain (Madrid) is founded in partnership with the Swiss Serum and Vaccine Institute. 1973: Grupo Farma’s manufacturing plant in Caracas, Venezuela, is inaugurated, signing, that same year, exclusive licenses in Venezuela with Astra Laboratories (Sweden) and Kabi Vitrum (Sweden). 1981: The Galenic Development Department was created in Caracas. • Grupo Farma obtained international patents for Teobid® (theophylline ER) and Valpron® (valproic acid). • An exclusive manufacturing and distribution contract for Alcon Pharmaceutical products was signed. • It signed a manufacturing contract with The Sydney Ross Co. (USA) when the latter closed its plant in Venezuela. • The Group licensed pharmaceutical lines from Sanofi (France), American Cyanamid–Lederle (USA), Marion Laboratories (USA), and Hausmann Laboratories, St. Gallen (Switzerland). 1997: Grupo Farma Ecuador is founded, expanding our operations in the Andean region. In this same year, Grupo Farma continued its internationalization by launching activities in Central America. • 50th anniversary of Laboratorios Farma, Venezuela. 1991: Acquisition of the company Norwich Eaton (a pharmaceutical subsidiary of Procter & Gamble in Venezuela), which afterward became the OTC Division of Grupo Farma. • Acquisition of the brand Yodora (Colombia). • The Group obtained licenses for pharmaceutical lines from Astra (Sweden) for Colombia, Schwarz Pharma (Germany), and Grossman (later known as Valeant-Mexico). • Co-Marketing with Pfizer (USA) in Venezuela. 2001: Purchase of Eli Lilly’s pharmaceutical production plant in Maracay, Venezuela. Beginning of its reconstruction.
• Strategic alliance with Aché Pharmaceutical Laboratories (Brazil). • Strategic alliance with Laboratorios Liomont (Mexico), benefiting Grupo Farma in various countries. 2002: We continued to grow in the Andean region by inaugurating Farmakonsuma in Peru. 2006: Laboratorios Farma in Venezuela celebrates its 65th anniversary. 2003: Acquisition of the brand Milpax for the business units in the different countries where the Group is present. 2008: The Group’s new manufacturing plant starts operating in Maracay, Venezuela. 2009: Acquisition of Profarma in Zug, Switzerland, for the distribution and promotion of pharmaceutical products.
2011: Acquisition of Gache laboratories in Caracas, Venezuela • Agreements with companies that have biotechnological products for their registration and commercialization in the region. • Laboratorios Farma,Venezuela, celebrates its 70th anniversary. 2012: Acquisition of various brands of James Brown Laboratories, (Ecuador). 2019: Acquisition of the Hepalive brand, (Ecuador). 2018: Acquisition of Quiprofarma Laboratories, (Colombia). 2020: Signing of an agreement for the marketing of Laboratorios Vifor products in Ecuador and Peru, and the renewal of the license agreement in Colombia, subscribed in 1984. 2021: Laboratorios Farma, Venezuela, celebrates its 80th Anniversary. 2023: Marketing and Distribution Agreement of P&G Health products in Venezuela.
• Strategic alliance with Glaxosmithkline (GSK) in Venezuela.
• Obtaining the INVIMA certification of Colombia.
Scroll Up